LONDON - Brussels on Wednesday published a long-awaited draft of its proposed overhaul of laws governing the European Union’s pharmaceuticals industry, setting up a tussle with drugmakers which warn they will invest and innovate elsewhere.
The Commission proposes to cut the length of basic market exclusivity that drugmakers get before generics can enter the market from 10 to eight years. Following publication, the European Parliament, Commission and member states will now thrash out final details of the law, which could take years.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação: